Epitope-Directed Antibody Development and Enhancement for Broad-Spectrum Fentanyl-Class Substance Detection: From Rational Hapten Design to On-Site Analysis
Analytical Chemistry · 05.05.2026 · 98 (17) · 12560-12573
DOI: 10.1021/acs.analchem.5c08177 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 18.04.2026. Verfasst von Xiaoyi Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China. Hauptthemen laut MEDLINE: Haptens, Fentanyl, Antibodies, Monoclonal, Epitopes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
The abuse of fentanyl and its analogues poses a severe threat to public health, making the development of robust detection tools crucial for effective surveillance. However, the whole category control of fentanyl makes it tough to monitor and regulate, as producers exploit extensive structural modifications to evade detection. To address this, we employed an epitope-directed hapten design strategy, systematically targeting three distinct regions of the fentanyl core structure. After immunization and hybridoma technology, three monoclonal antibodies (mAbs) with nanomolar affinity and tunable cross-reactivity profiles were generated. Furthermore, homology modeling and molecular docking elucidated the structural basis of their distinct binding patterns, establishing a clear link between hapten design and the antibody recognition function. Finally, leveraging these mAbs, we developed a highly sensitive indirect competitive enzyme-linked immunosorbent assay (ic-ELISA) for the simultaneous detection of 32 fentanyl analogues (IC50 value = 0.072-101.7 ng/mL). Furthermore, a rapid gold nanoparticle-based immunochromatographic assay (GICA) with a cutoff value of 5 ng/mL was established and demonstrated its utility as a robust on-site tool. Both assays showed excellent accuracy in spiked human urine and hair samples, with recovery rates of 80.20-118.65%. This work provides not only a powerful tool for the surveillance of fentanyl analogues in complex biological matrices but also a rational hapten design framework for generating antibodies with tunable properties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China.
- Office of China National Narcotics Control Commission, China Pharmaceutical University Joint Laboratory on Key Technologies of Narcotics Control, Nanjing 210009, China.
- Key Laboratory of Drug Monitoring and Control, Drug Intelligence and Forensic Center, Ministry of Public Security, Beijing 100193, China.
ORCID-Profile: Bingjie Zou, Bin Di
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Chen, X., Chi, X., Hu, Y., Gao, X., Wang, X., Shu, Y., Wei, D., Xu, P., Zou, B., & Di, B. (2026). Epitope-Directed Antibody Development and Enhancement for Broad-Spectrum Fentanyl-Class Substance Detection: From Rational Hapten Design to On-Site Analysis. Analytical Chemistry, 98(17), 12560-12573. https://doi.org/10.1021/acs.analchem.5c08177
Vancouver
Chen X, Chi X, Hu Y, Gao X, Wang X, Shu Y, et al. Epitope-Directed Antibody Development and Enhancement for Broad-Spectrum Fentanyl-Class Substance Detection: From Rational Hapten Design to On-Site Analysis. Analytical Chemistry. 2026;98(17):12560-12573. doi:10.1021/acs.analchem.5c08177
BibTeX
@article{Chen2026,
author = {Chen, Xiaoyi and Chi, Xiang and Hu, Yuxi and Gao, Xinyi and Wang, Xin and Shu, Yawen and Wei, Daichun and Xu, Peng and Zou, Bingjie and Di, Bin},
title = {Epitope-Directed Antibody Development and Enhancement for Broad-Spectrum Fentanyl-Class Substance Detection: From Rational Hapten Design to On-Site Analysis},
journal = {Analytical Chemistry},
year = {2026},
volume = {98},
number = {17},
pages = {12560--12573},
doi = {10.1021/acs.analchem.5c08177}
}
EUVIMED